News

As we approach the midpoint of the 21st century, the pharmaceutical industry is undergoing a profound transformation driven by the rapid advancement of technology. In 2024, we will witness a seismic shift in how drugs are developed, manufactured, and...

Since artificial intelligence (AI) has the exciting potential to transform every sector and change established processes, it is now the talk of the town. The pharmaceutical industry is one of the many areas that AI is starting to have...

The Medical Device Contract Manufacturing Market is currently seeing robust growth due to the increasing demand for advanced medical devices, the rising prevalence of chronic diseases, and the shift of medical device companies towards outsourcing to concentrate on their...

The FDA has released a preliminary guide to aid developers of drug-device combination products in creating essential drug delivery outputs- EDDOs that ensure consistent performance. Products covered by this guide include syringes, injectors, infusion products, nasal sprays, inhalers, nebulizers,...

Throughout the last four to five years, there has been a persistent problem, which was noted by Willus Fisher, a doctoral candidate at UC Santa Barbara, while teaching pharmacology to students. He remarked that each year, he reiterated the trade-offs...

European Pharmacopoeia, during its 179th session in June 2024, confirmed the removal of the rabbit pyrogen test- RPT from its monographs. As explained by the European Directorate for the Quality of Medicines- EDQM, the RPT has been the traditional method...

The biopharma industry is well-positioned to respond to upcoming patent expirations by pursuing mergers and acquisitions, according to a research note from Morgan Stanley. The report, dated July 11, states that products losing exclusivity through 2030 generate a combined...